OUTLOOK THERAPEUTICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31)
OUTLOOK THERAPEUTICS, INC. (OTLK) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) of $10.97 million as of 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Notes
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 · last filed 2020-08-14
- 2020-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) $10.97M.
- 2020-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) -$20.52M.
- 2019-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) -$30.93M.
- 2019-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) -$16.13M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) as first filed |
|---|---|---|
| 2020-06-30 | $10.97M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$20.52M 10-Q · filed 2020-08-14 | |
| 2019-12-31 | -$30.93M 10-Q · filed 2020-05-15 | |
| 2019-09-30 | -$16.13M 10-Q · filed 2020-08-14 | |
| 2019-06-30 | -$6.56M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | -$28.09M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | -$26.35M 10-Q · filed 2020-05-15 | |
| 2018-09-30 | -$25.54M 10-Q · filed 2020-08-14 | |
| 2018-06-30 | -$13.20M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | -$33.57M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | -$25.09M 10-Q · filed 2019-05-15 | |
| 2017-09-30 | -$33.65M 10-K · filed 2019-12-19 | |
| 2016-09-30 | -$5.17M 10-K · filed 2018-12-18 | -$5.20M 10-K · filed 2016-12-29 |
| 2016-06-30 | $1.56M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$37.86M 10-Q · filed 2016-06-27 | |
| 2015-09-30 | -$54.87M 10-K · filed 2017-12-29 | |
| 2014-09-30 | -$45.15M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |